- 4.8Impact Factor
- 9.2CiteScore
- 18 daysTime to First Decision
Biomolecules, Volume 8, Issue 3
2018 September - 55 articles
Cover Story: Different studies have recently shown that flavonoids have the potential to inhibit BET domains, which holds great interest for the treatment of cancer and inflammatory diseases. Here, we conducted a binding characterization of the flavonoid amentoflavone (AF) against BRD4. We observed that AF makes numerous contacts in the ZA channel, in addition to showing that AF can potentially make contacts with non-canonical residues. Enzymatic inhibitory assays confirmed the activity of AF. These preliminary results offer a new paradigm for BET inhibitor design.View Paper here.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

